Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOSTARLIMAB-GXLY vs DOXERCALCIFEROL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOSTARLIMAB-GXLY vs DOXERCALCIFEROL: Safety Overview

Metric DOSTARLIMAB-GXLY DOXERCALCIFEROL
Total FAERS Reports 504 137
Deaths Reported 55 7
Death Rate 10.9% 5.1%
Hospitalizations 126 34
Average Patient Age 67.4 yrs 54.9 yrs
% Female Patients 92.7% 50.0%
FDA Approval Date N/A Apr 23, 2004
Manufacturer N/A Alembic Pharmaceuticals Inc.
Route N/A INTRAVENOUS
Marketing Status Prescription Discontinued